▶ 調査レポート

核医学/放射性医薬品の世界市場2018

• 英文タイトル:Global Nuclear Medicine/Radiopharmaceuticals Sales Market Report 2018
• レポートコード:D107042
• 出版社/出版日:QYResearch / 2018年10月
• レポート形態:英文、PDF、109ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:製薬・医療
• 販売価格(消費税別)
  Single User License¥440,000 (USD4,000)▷ お問い合わせ
  Enterprise License¥880,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、核医学/放射性医薬品の世界市場について調査・分析し、核医学/放射性医薬品のメーカー別販売量、市場シェア分析、種類別販売分析(診断、治療)、用途別販売分析(腫瘍学、甲状腺、心臓病学)、地域別販売分析(米国、中国、欧州、日本、東南アジア、インド)、価格動向、企業動向、核医学/放射性医薬品産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。

・核医学/放射性医薬品市場概要
・核医学/放射性医薬品のメーカー別販売量・メーカー別シェア
・核医学/放射性医薬品の世界市場:種類別販売量(診断、治療)
・核医学/放射性医薬品の世界市場:用途別販売量(腫瘍学、甲状腺、心臓病学)
・核医学/放射性医薬品の世界市場:地域別販売量・市場シェア
・核医学/放射性医薬品の米国市場規模
・核医学/放射性医薬品の中国市場規模
・核医学/放射性医薬品の欧州市場規模
・核医学/放射性医薬品の日本市場規模
・核医学/放射性医薬品の東南アジア市場規模
・核医学/放射性医薬品のインド市場規模
・核医学/放射性医薬品のメーカー別分析(企業概要、事業概要、製品概要、収益、価格等)
・核医学/放射性医薬品のコスト分析・価格動向
・核医学/放射性医薬品の産業チェーン(サプライチェーン分析)
・核医学/放射性医薬品のマーケティング戦略・販売チャネル、流通業者
・核医学/放射性医薬品市場への影響要因分析
・核医学/放射性医薬品の世界市場予測
・核医学/放射性医薬品の米国市場予測
・核医学/放射性医薬品の中国市場予測
・核医学/放射性医薬品の欧州市場予測
・核医学/放射性医薬品の日本市場予測
・核医学/放射性医薬品の東南アジア市場予測
・核医学/放射性医薬品のインド市場予測
・核医学/放射性医薬品の種類別世界市場予測(診断、治療)
・核医学/放射性医薬品の用途別世界市場予測(腫瘍学、甲状腺、心臓病学)
...

This report studies the global Nuclear Medicine/Radiopharmaceuticals market status and forecast, categorizes the global Nuclear Medicine/Radiopharmaceuticals market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).
Radiopharmaceuticals (also known as radioactive drugs) are drugs that contain radionuclides that emit radiation. The distribution of the radiopharmaceutical within the body is determined by the physiochemical properties of the drug, the stability of the radiolabel, the purity of the radiopharmaceutical preparation, the pathophysiologic state of the patient, and the presence or absence of interfering drugs. Dynamic and static images of the distribution of the radiopharmaceutical within the body can be obtained using a g-camera or another suitable instrument appropriate for the radiopharmaceutical being imaged—for example, positronemitting radiopharmaceuticals.
Nuclear medicine is a medical specialty that allows modern diagnostics and treatments using radiopharmaceuticals original radiotracers. Radiopharmaceuticals are considered a special group of drugs and thus their preparation and use are regulated by a set of policies that have been adopted by individual member countries. In China, radioactive drug approval process is cumbersome, drug research and development cycle is too long and the high-end equipment of China mainly relies on imports, which restrict the development of nuclear medicine.
In application, nuclear medicine / radiopharmaceuticals is for treatment oncology, thyroid, cardiology and other dieses. The nuclear medicine / radiopharmaceuticals market is mainly driven by growing demand for treatment cardiology which accounts for nearly 42.19 % of total downstream consumption of Nuclear Medicine / Radiopharmaceuticals in China.
The global Nuclear Medicine/Radiopharmaceuticals market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.

The major players covered in this report
China Isotope & Radiation
Dongcheng
Jaco
Ciaeriar
Advanced Molecular-imaging Solution
Shanghai Atom Kexing

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
United States
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Diagnostic
Therapeutic
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Oncology
Thyroid
Cardiology

The study objectives of this report are:
To analyze and study the global Nuclear Medicine/Radiopharmaceuticals sales, value, status (2013-2017) and forecast (2018-2025);
To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
Focuses on the key Nuclear Medicine/Radiopharmaceuticals players, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Nuclear Medicine/Radiopharmaceuticals are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Nuclear Medicine/Radiopharmaceuticals Manufacturers
Nuclear Medicine/Radiopharmaceuticals Distributors/Traders/Wholesalers
Nuclear Medicine/Radiopharmaceuticals Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company’s specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Nuclear Medicine/Radiopharmaceuticals market, by end-use.
Detailed analysis and profiles of additional market players.

レポート目次

Table of Contents

Global Nuclear Medicine/Radiopharmaceuticals Sales Market Report 2018
1 Nuclear Medicine/Radiopharmaceuticals Market Overview
1.1 Product Overview and Scope of Nuclear Medicine/Radiopharmaceuticals
1.2 Classification of Nuclear Medicine/Radiopharmaceuticals by Product Category
1.2.1 Global Nuclear Medicine/Radiopharmaceuticals Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 Global Nuclear Medicine/Radiopharmaceuticals Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 Diagnostic
1.2.4 Therapeutic
1.3 Global Nuclear Medicine/Radiopharmaceuticals Market by Application/End Users
1.3.1 Global Nuclear Medicine/Radiopharmaceuticals Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.1 Oncology
1.3.2 Thyroid
1.3.3 Cardiology
1.4 Global Nuclear Medicine/Radiopharmaceuticals Market by Region
1.4.1 Global Nuclear Medicine/Radiopharmaceuticals Market Size (Value) Comparison by Region (2013-2025)
1.4.2 United States Nuclear Medicine/Radiopharmaceuticals Status and Prospect (2013-2025)
1.4.3 Europe Nuclear Medicine/Radiopharmaceuticals Status and Prospect (2013-2025)
1.4.4 China Nuclear Medicine/Radiopharmaceuticals Status and Prospect (2013-2025)
1.4.5 Japan Nuclear Medicine/Radiopharmaceuticals Status and Prospect (2013-2025)
1.4.6 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Status and Prospect (2013-2025)
1.4.7 India Nuclear Medicine/Radiopharmaceuticals Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Nuclear Medicine/Radiopharmaceuticals (2013-2025)
1.5.1 Global Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2013-2025)
1.5.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2013-2025)

2 Global Nuclear Medicine/Radiopharmaceuticals Competition by Players/Suppliers, Type and Application
2.1 Global Nuclear Medicine/Radiopharmaceuticals Market Competition by Players/Suppliers
2.1.1 Global Nuclear Medicine/Radiopharmaceuticals Sales and Market Share of Key Players/Suppliers (2013-2018)
2.1.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Nuclear Medicine/Radiopharmaceuticals (Volume and Value) by Type
2.2.1 Global Nuclear Medicine/Radiopharmaceuticals Sales and Market Share by Type (2013-2018)
2.2.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue and Market Share by Type (2013-2018)
2.3 Global Nuclear Medicine/Radiopharmaceuticals (Volume and Value) by Region
2.3.1 Global Nuclear Medicine/Radiopharmaceuticals Sales and Market Share by Region (2013-2018)
2.3.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue and Market Share by Region (2013-2018)
2.4 Global Nuclear Medicine/Radiopharmaceuticals (Volume) by Application

3 United States Nuclear Medicine/Radiopharmaceuticals (Volume, Value and Sales Price)
3.1 United States Nuclear Medicine/Radiopharmaceuticals Sales and Value (2013-2018)
3.1.1 United States Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2013-2018)
3.1.2 United States Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2013-2018)
3.1.3 United States Nuclear Medicine/Radiopharmaceuticals Sales Price Trend (2013-2018)
3.2 United States Nuclear Medicine/Radiopharmaceuticals Sales Volume and Market Share by Players (2013-2018)
3.3 United States Nuclear Medicine/Radiopharmaceuticals Sales Volume and Market Share by Type (2013-2018)
3.4 United States Nuclear Medicine/Radiopharmaceuticals Sales Volume and Market Share by Application (2013-2018)

4 Europe Nuclear Medicine/Radiopharmaceuticals (Volume, Value and Sales Price)
4.1 Europe Nuclear Medicine/Radiopharmaceuticals Sales and Value (2013-2018)
4.1.1 Europe Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2013-2018)
4.1.2 Europe Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2013-2018)
4.1.3 Europe Nuclear Medicine/Radiopharmaceuticals Sales Price Trend (2013-2018)
4.2 Europe Nuclear Medicine/Radiopharmaceuticals Sales Volume and Market Share by Players (2013-2018)
4.3 Europe Nuclear Medicine/Radiopharmaceuticals Sales Volume and Market Share by Type (2013-2018)
4.4 Europe Nuclear Medicine/Radiopharmaceuticals Sales Volume and Market Share by Application (2013-2018)

5 China Nuclear Medicine/Radiopharmaceuticals (Volume, Value and Sales Price)
5.1 China Nuclear Medicine/Radiopharmaceuticals Sales and Value (2013-2018)
5.1.1 China Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2013-2018)
5.1.2 China Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2013-2018)
5.1.3 China Nuclear Medicine/Radiopharmaceuticals Sales Price Trend (2013-2018)
5.2 China Nuclear Medicine/Radiopharmaceuticals Sales Volume and Market Share by Players (2013-2018)
5.3 China Nuclear Medicine/Radiopharmaceuticals Sales Volume and Market Share by Type (2013-2018)
5.4 China Nuclear Medicine/Radiopharmaceuticals Sales Volume and Market Share by Application (2013-2018)

6 Japan Nuclear Medicine/Radiopharmaceuticals (Volume, Value and Sales Price)
6.1 Japan Nuclear Medicine/Radiopharmaceuticals Sales and Value (2013-2018)
6.1.1 Japan Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2013-2018)
6.1.2 Japan Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2013-2018)
6.1.3 Japan Nuclear Medicine/Radiopharmaceuticals Sales Price Trend (2013-2018)
6.2 Japan Nuclear Medicine/Radiopharmaceuticals Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Nuclear Medicine/Radiopharmaceuticals Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Nuclear Medicine/Radiopharmaceuticals Sales Volume and Market Share by Application (2013-2018)

7 Southeast Asia Nuclear Medicine/Radiopharmaceuticals (Volume, Value and Sales Price)
7.1 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales and Value (2013-2018)
7.1.1 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2013-2018)
7.1.2 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2013-2018)
7.1.3 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales Price Trend (2013-2018)
7.2 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales Volume and Market Share by Application (2013-2018)

8 India Nuclear Medicine/Radiopharmaceuticals (Volume, Value and Sales Price)
8.1 India Nuclear Medicine/Radiopharmaceuticals Sales and Value (2013-2018)
8.1.1 India Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2013-2018)
8.1.2 India Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2013-2018)
8.1.3 India Nuclear Medicine/Radiopharmaceuticals Sales Price Trend (2013-2018)
8.2 India Nuclear Medicine/Radiopharmaceuticals Sales Volume and Market Share by Players (2013-2018)
8.3 India Nuclear Medicine/Radiopharmaceuticals Sales Volume and Market Share by Type (2013-2018)
8.4 India Nuclear Medicine/Radiopharmaceuticals Sales Volume and Market Share by Application (2013-2018)

9 Global Nuclear Medicine/Radiopharmaceuticals Players/Suppliers Profiles and Sales Data
9.1 China Isotope & Radiation
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Nuclear Medicine/Radiopharmaceuticals Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2013-2018)
9.1.4 Main Business/Business Overview
9.2 Dongcheng
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Nuclear Medicine/Radiopharmaceuticals Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Dongcheng Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2013-2018)
9.2.4 Main Business/Business Overview
9.3 Jaco
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Nuclear Medicine/Radiopharmaceuticals Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Jaco Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2013-2018)
9.3.4 Main Business/Business Overview
9.4 Ciaeriar
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Nuclear Medicine/Radiopharmaceuticals Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Ciaeriar Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2013-2018)
9.4.4 Main Business/Business Overview
9.5 Advanced Molecular-imaging Solution
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Nuclear Medicine/Radiopharmaceuticals Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2013-2018)
9.5.4 Main Business/Business Overview
9.6 Shanghai Atom Kexing
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Nuclear Medicine/Radiopharmaceuticals Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2013-2018)
9.6.4 Main Business/Business Overview

10 Nuclear Medicine/Radiopharmaceuticals Maufacturing Cost Analysis
10.1 Nuclear Medicine/Radiopharmaceuticals Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Nuclear Medicine/Radiopharmaceuticals
10.3 Manufacturing Process Analysis of Nuclear Medicine/Radiopharmaceuticals

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Nuclear Medicine/Radiopharmaceuticals Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Nuclear Medicine/Radiopharmaceuticals Major Manufacturers in 2017
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Nuclear Medicine/Radiopharmaceuticals Market Forecast (2018-2025)
14.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global Nuclear Medicine/Radiopharmaceuticals Price and Trend Forecast (2018-2025)
14.2 Global Nuclear Medicine/Radiopharmaceuticals Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States Nuclear Medicine/Radiopharmaceuticals Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 Europe Nuclear Medicine/Radiopharmaceuticals Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 China Nuclear Medicine/Radiopharmaceuticals Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan Nuclear Medicine/Radiopharmaceuticals Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India Nuclear Medicine/Radiopharmaceuticals Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Nuclear Medicine/Radiopharmaceuticals Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Type (2018-2025)
14.3.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Type (2018-2025)
14.3.3 Global Nuclear Medicine/Radiopharmaceuticals Price Forecast by Type (2018-2025)
14.4 Global Nuclear Medicine/Radiopharmaceuticals Sales Volume Forecast by Application (2018-2025)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Nuclear Medicine/Radiopharmaceuticals
Figure Global Nuclear Medicine/Radiopharmaceuticals Sales Volume Comparison (K Units) by Type (2013-2025)
Figure Global Nuclear Medicine/Radiopharmaceuticals Sales Volume Market Share by Type (Product Category) in 2017
Figure Diagnostic Product Picture
Figure Therapeutic Product Picture
Figure Global Nuclear Medicine/Radiopharmaceuticals Sales Comparison (K Units) by Application (2013-2025)
Figure Global Sales Market Share of Nuclear Medicine/Radiopharmaceuticals by Application in 2017
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Thyroid Examples
Table Key Downstream Customer in Thyroid
Figure Cardiology Examples
Table Key Downstream Customer in Cardiology
Figure Global Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) by Regions (2013-2025)
Figure United States Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Nuclear Medicine/Radiopharmaceuticals Sales Volume (K Units) and Growth Rate (2013-2025)
Figure Global Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Nuclear Medicine/Radiopharmaceuticals Sales Volume (K Units) (2013-2018)
Table Global Nuclear Medicine/Radiopharmaceuticals Sales (K Units) of Key Players/Suppliers (2013-2018)
Table Global Nuclear Medicine/Radiopharmaceuticals Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Nuclear Medicine/Radiopharmaceuticals Sales Share by Players/Suppliers
Figure 2017 Nuclear Medicine/Radiopharmaceuticals Sales Share by Players/Suppliers
Figure Global Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Nuclear Medicine/Radiopharmaceuticals Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Nuclear Medicine/Radiopharmaceuticals Revenue Share by Players
Table 2017 Global Nuclear Medicine/Radiopharmaceuticals Revenue Share by Players
Table Global Nuclear Medicine/Radiopharmaceuticals Sales (K Units) and Market Share by Type (2013-2018)
Table Global Nuclear Medicine/Radiopharmaceuticals Sales Share (K Units) by Type (2013-2018)
Figure Sales Market Share of Nuclear Medicine/Radiopharmaceuticals by Type (2013-2018)
Figure Global Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate by Type (2013-2018)
Table Global Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Nuclear Medicine/Radiopharmaceuticals Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Nuclear Medicine/Radiopharmaceuticals by Type (2013-2018)
Figure Global Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate by Type (2013-2018)
Table Global Nuclear Medicine/Radiopharmaceuticals Sales Volume (K Units) and Market Share by Region (2013-2018)
Table Global Nuclear Medicine/Radiopharmaceuticals Sales Share by Region (2013-2018)
Figure Sales Market Share of Nuclear Medicine/Radiopharmaceuticals by Region (2013-2018)
Figure Global Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate by Region in 2017
Table Global Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Nuclear Medicine/Radiopharmaceuticals Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Nuclear Medicine/Radiopharmaceuticals by Region (2013-2018)
Figure Global Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate by Region in 2017
Table Global Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Nuclear Medicine/Radiopharmaceuticals Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Nuclear Medicine/Radiopharmaceuticals by Region (2013-2018)
Figure Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Region in 2017
Table Global Nuclear Medicine/Radiopharmaceuticals Sales Volume (K Units) and Market Share by Application (2013-2018)
Table Global Nuclear Medicine/Radiopharmaceuticals Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Nuclear Medicine/Radiopharmaceuticals by Application (2013-2018)
Figure Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2013-2018)
Figure United States Nuclear Medicine/Radiopharmaceuticals Sales (K Units) and Growth Rate (2013-2018)
Figure United States Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Nuclear Medicine/Radiopharmaceuticals Sales Price (USD/Unit) Trend (2013-2018)
Table United States Nuclear Medicine/Radiopharmaceuticals Sales Volume (K Units) by Players (2013-2018)
Table United States Nuclear Medicine/Radiopharmaceuticals Sales Volume Market Share by Players (2013-2018)
Figure United States Nuclear Medicine/Radiopharmaceuticals Sales Volume Market Share by Players in 2017
Table United States Nuclear Medicine/Radiopharmaceuticals Sales Volume (K Units) by Type (2013-2018)
Table United States Nuclear Medicine/Radiopharmaceuticals Sales Volume Market Share by Type (2013-2018)
Figure United States Nuclear Medicine/Radiopharmaceuticals Sales Volume Market Share by Type in 2017
Table United States Nuclear Medicine/Radiopharmaceuticals Sales Volume (K Units) by Application (2013-2018)
Table United States Nuclear Medicine/Radiopharmaceuticals Sales Volume Market Share by Application (2013-2018)
Figure United States Nuclear Medicine/Radiopharmaceuticals Sales Volume Market Share by Application in 2017
Figure Europe Nuclear Medicine/Radiopharmaceuticals Sales (K Units) and Growth Rate (2013-2018)
Figure Europe Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Nuclear Medicine/Radiopharmaceuticals Sales Price (USD/Unit) Trend (2013-2018)
Table Europe Nuclear Medicine/Radiopharmaceuticals Sales Volume (K Units) by Players (2013-2018)
Table Europe Nuclear Medicine/Radiopharmaceuticals Sales Volume Market Share by Players (2013-2018)
Figure Europe Nuclear Medicine/Radiopharmaceuticals Sales Volume Market Share by Players in 2017
Table Europe Nuclear Medicine/Radiopharmaceuticals Sales Volume (K Units) by Type (2013-2018)
Table Europe Nuclear Medicine/Radiopharmaceuticals Sales Volume Market Share by Type (2013-2018)
Figure Europe Nuclear Medicine/Radiopharmaceuticals Sales Volume Market Share by Type in 2017
Table Europe Nuclear Medicine/Radiopharmaceuticals Sales Volume (K Units) by Application (2013-2018)
Table Europe Nuclear Medicine/Radiopharmaceuticals Sales Volume Market Share by Application (2013-2018)
Figure Europe Nuclear Medicine/Radiopharmaceuticals Sales Volume Market Share by Application in 2017
Figure China Nuclear Medicine/Radiopharmaceuticals Sales (K Units) and Growth Rate (2013-2018)
Figure China Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Nuclear Medicine/Radiopharmaceuticals Sales Price (USD/Unit) Trend (2013-2018)
Table China Nuclear Medicine/Radiopharmaceuticals Sales Volume (K Units) by Players (2013-2018)
Table China Nuclear Medicine/Radiopharmaceuticals Sales Volume Market Share by Players (2013-2018)
Figure China Nuclear Medicine/Radiopharmaceuticals Sales Volume Market Share by Players in 2017
Table China Nuclear Medicine/Radiopharmaceuticals Sales Volume (K Units) by Type (2013-2018)
Table China Nuclear Medicine/Radiopharmaceuticals Sales Volume Market Share by Type (2013-2018)
Figure China Nuclear Medicine/Radiopharmaceuticals Sales Volume Market Share by Type in 2017
Table China Nuclear Medicine/Radiopharmaceuticals Sales Volume (K Units) by Application (2013-2018)
Table China Nuclear Medicine/Radiopharmaceuticals Sales Volume Market Share by Application (2013-2018)
Figure China Nuclear Medicine/Radiopharmaceuticals Sales Volume Market Share by Application in 2017
Figure Japan Nuclear Medicine/Radiopharmaceuticals Sales (K Units) and Growth Rate (2013-2018)
Figure Japan Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Nuclear Medicine/Radiopharmaceuticals Sales Price (USD/Unit) Trend (2013-2018)
Table Japan Nuclear Medicine/Radiopharmaceuticals Sales Volume (K Units) by Players (2013-2018)
Table Japan Nuclear Medicine/Radiopharmaceuticals Sales Volume Market Share by Players (2013-2018)
Figure Japan Nuclear Medicine/Radiopharmaceuticals Sales Volume Market Share by Players in 2017
Table Japan Nuclear Medicine/Radiopharmaceuticals Sales Volume (K Units) by Type (2013-2018)
Table Japan Nuclear Medicine/Radiopharmaceuticals Sales Volume Market Share by Type (2013-2018)
Figure Japan Nuclear Medicine/Radiopharmaceuticals Sales Volume Market Share by Type in 2017
Table Japan Nuclear Medicine/Radiopharmaceuticals Sales Volume (K Units) by Application (2013-2018)
Table Japan Nuclear Medicine/Radiopharmaceuticals Sales Volume Market Share by Application (2013-2018)
Figure Japan Nuclear Medicine/Radiopharmaceuticals Sales Volume Market Share by Application in 2017
Figure Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales (K Units) and Growth Rate (2013-2018)
Figure Southeast Asia Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales Price (USD/Unit) Trend (2013-2018)
Table Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales Volume (K Units) by Players (2013-2018)
Table Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales Volume Market Share by Players in 2017
Table Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales Volume (K Units) by Type (2013-2018)
Table Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales Volume Market Share by Type in 2017
Table Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales Volume (K Units) by Application (2013-2018)
Table Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales Volume Market Share by Application in 2017
Figure India Nuclear Medicine/Radiopharmaceuticals Sales (K Units) and Growth Rate (2013-2018)
Figure India Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Nuclear Medicine/Radiopharmaceuticals Sales Price (USD/Unit) Trend (2013-2018)
Table India Nuclear Medicine/Radiopharmaceuticals Sales Volume (K Units) by Players (2013-2018)
Table India Nuclear Medicine/Radiopharmaceuticals Sales Volume Market Share by Players (2013-2018)
Figure India Nuclear Medicine/Radiopharmaceuticals Sales Volume Market Share by Players in 2017
Table India Nuclear Medicine/Radiopharmaceuticals Sales Volume (K Units) by Type (2013-2018)
Table India Nuclear Medicine/Radiopharmaceuticals Sales Volume Market Share by Type (2013-2018)
Figure India Nuclear Medicine/Radiopharmaceuticals Sales Volume Market Share by Type in 2017
Table India Nuclear Medicine/Radiopharmaceuticals Sales Volume (K Units) by Application (2013-2018)
Table India Nuclear Medicine/Radiopharmaceuticals Sales Volume Market Share by Application (2013-2018)
Figure India Nuclear Medicine/Radiopharmaceuticals Sales Volume Market Share by Application in 2017
Table China Isotope & Radiation Basic Information List
Table China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2013-2018)
Figure China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Sales Global Market Share (2013-2018)
Figure China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Revenue Global Market Share (2013-2018)
Table Dongcheng Basic Information List
Table Dongcheng Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Dongcheng Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2013-2018)
Figure Dongcheng Nuclear Medicine/Radiopharmaceuticals Sales Global Market Share (2013-2018)
Figure Dongcheng Nuclear Medicine/Radiopharmaceuticals Revenue Global Market Share (2013-2018)
Table Jaco Basic Information List
Table Jaco Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Jaco Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2013-2018)
Figure Jaco Nuclear Medicine/Radiopharmaceuticals Sales Global Market Share (2013-2018
Figure Jaco Nuclear Medicine/Radiopharmaceuticals Revenue Global Market Share (2013-2018)
Table Ciaeriar Basic Information List
Table Ciaeriar Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Ciaeriar Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2013-2018)
Figure Ciaeriar Nuclear Medicine/Radiopharmaceuticals Sales Global Market Share (2013-2018)
Figure Ciaeriar Nuclear Medicine/Radiopharmaceuticals Revenue Global Market Share (2013-2018)
Table Advanced Molecular-imaging Solution Basic Information List
Table Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2013-2018)
Figure Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Sales Global Market Share (2013-2018)
Figure Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Revenue Global Market Share (2013-2018)
Table Shanghai Atom Kexing Basic Information List
Table Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2013-2018)
Figure Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Sales Global Market Share (2013-2018
Figure Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Revenue Global Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nuclear Medicine/Radiopharmaceuticals
Figure Manufacturing Process Analysis of Nuclear Medicine/Radiopharmaceuticals
Figure Nuclear Medicine/Radiopharmaceuticals Industrial Chain Analysis
Table Raw Materials Sources of Nuclear Medicine/Radiopharmaceuticals Major Players in 2017
Table Major Buyers of Nuclear Medicine/Radiopharmaceuticals
Table Distributors/Traders List
Figure Global Nuclear Medicine/Radiopharmaceuticals Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Global Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Nuclear Medicine/Radiopharmaceuticals Price (USD/Unit) and Trend Forecast (2018-2025)
Table Global Nuclear Medicine/Radiopharmaceuticals Sales Volume (K Units) Forecast by Regions (2018-2025)
Figure Global Nuclear Medicine/Radiopharmaceuticals Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Nuclear Medicine/Radiopharmaceuticals Sales Volume Market Share Forecast by Regions in 2025
Table Global Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share Forecast by Regions in 2025
Figure United States Nuclear Medicine/Radiopharmaceuticals Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Europe Nuclear Medicine/Radiopharmaceuticals Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Europe Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate Forecast (2018-2025)
Figure China Nuclear Medicine/Radiopharmaceuticals Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure China Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Nuclear Medicine/Radiopharmaceuticals Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Japan Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Nuclear Medicine/Radiopharmaceuticals Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure India Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Nuclear Medicine/Radiopharmaceuticals Sales (K Units) Forecast by Type (2018-2025)
Figure Global Nuclear Medicine/Radiopharmaceuticals Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share Forecast by Type (2018-2025)
Table Global Nuclear Medicine/Radiopharmaceuticals Price (USD/Unit) Forecast by Type (2018-2025)
Table Global Nuclear Medicine/Radiopharmaceuticals Sales (K Units) Forecast by Application (2018-2025)
Figure Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources



• 英文レポート名:Global Nuclear Medicine/Radiopharmaceuticals Sales Market Report 2018
• 日本語訳:核医学/放射性医薬品の世界市場2018
• レポートコード:D107042お問い合わせ(見積依頼・ご注文・質問)